Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Does grapefruit juice's effect on lipitor extend to other foods?Is lipitor's long term use recommended to prevent heart disease?Can wine mimic lipitor's role in reducing plaque buildup?Can lipitor change red wine's appeal for you?Can you provide a breakdown of yervoy's discounted cost?
See the DrugPatentWatch profile for cosentyx
While Cosentyx, also known as secukinumab, is a powerful biologic medication approved to treat various inflammatory conditions, including psoriasis and psoriatic arthritis, the effects of moderate wine consumption on its efficacy and safety are not extensively studied [1]. Therefore, it's essential to consult a doctor or pharmacist for personalized advice. Moderate wine consumption is generally considered as one to two glasses per occasion for men and one glass per occasion for women. Cosentyx can impair your immune system's function; consuming large amounts of wine may potentially increase this effect, possibly making the treatment less effective. However, if you can safely handle the combination, there is no conclusive evidence that small amounts of wine would drastically impair the efficacy of Cosentyx [2]. Moreover, secukinumab can cause several side effects, particularly when combined with other substances like alcohol [3]. Drinking heavily can worsen side effects such as diarrhea or exacerbate existing liver problems. It is also crucial to note that certain Cosentyx formulations contain lactose or other ingredients that might interact with wine. For the cautious use of wine alongside Cosentyx, follow these guidelines: - Limit your wine consumption to one moderate serving per occasion. - Stay hydrated and eat well-rounded meals to mitigate potential side effects. - Consult your doctor or healthcare provider to discuss the optimal approach for your specific situation. You can find more information about Cosentyx and its interactions on Drugs.com [4] or DrugPatentWatch.com [5]. Sources: [1] https://www.cosentyx.com/us-for-patients/prescribing-information [2] https://www.drugs.com/sfc/cosentyx-secukinumab-300-mg-per-milliliter-solution-for-intravenous-infusion-dosage-and-administration [3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441231 [4]https://www.drugs.com/cosentyx [5]https://www.drugpatentwatch.com/cosentyx/
Other Questions About Cosentyx :